Visual Capitalist July 11, 2023
With the world evolving at an unprecedented pace, nearly every sector is being disrupted in some way or another.
In transportation, EVs were spearheaded by Tesla, which emerged as the first new American automaker in decades, and is now one of the world’s most valuable companies. Similarly, in the realm of AI, OpenAI has taken a leading position in large language models, demonstrating the immense potential of the technology.
Now, we turn our attention to biotech, an industry that is developing innovative treatments at an accelerated pace. In this graphic from sponsor MSCI, we explain the growing pipeline of biotech treatments, and why this could benefit investors.
Growth in Clinical Drug Trials
A clinical drug trial is a study...
Today's Sponsors
Today's Sponsor